Mușat & Asociații is one of the first law firms established in Romania. For more than 29 years, the firm provides legal advisory services in all areas of business law, being an acknowledged market leader in Healthcare & Pharma, Mergers & Acquisitions, Corporate & Commercial, Competition & Antitrust, Intellectual Property, Public Procurement, Labor & Employee Benefits, Litigation & Arbitration, Criminal Law and Taxation.
Mușat & Asociații is recognized as one of the country’s most knowledgeable law firms in the life sciences sector, having advised an impressive portfolio of international clients over the years, including 9 of the top 12 innovative pharmaceutical companies worldwide, leading medical devices companies, private healthcare providers, contract research organizations and industry associations.
Leading pharmaceutical companies rely on Mușat & Asociații for complex projects and day-to-day issues, including without limitation to the marketing authorisation, distribution and promotion of medicinal products, the pricing and the reimbursement of medicines, the supply of medicines and medical devices under public procurement proceedings, cost-volume agreements, the clawback tax, the EFPIA/ARPIM guidelines, competition, IP, corporate, employment, data protection, tax issues, FCPA and various other compliance matters.
In a unique position to provide expert advice in all legal matters concerning these highly regulated sectors, the firm has achie- ved constant success due to the strength and depth of its legal team, which encompasses regulatory, corporate, antitrust and intellectual property attorneys, as well as extensive litigation resources. This array of talent enables the firm to consolidate its undisputed top-tier position while developing further expertise in the most sensitive issues and conducting landmark cases.
All about cannabinoid drugs, medicinal cannabis and opioid drugs in Romania. Prepared in association with Mușat & Asociații, a leading global law firm, this is an extract from The Pharma Legal Handbook: Romania, available to purchase here for USD 99. Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized in your country? According to the national catalogue of medicines in Romania published by NAMMD, currently there are no cannabinoid medicinal products authorized for marketing in the country. By law, certain psychotropic substances extracted from…
The ins and outs of regulatory reforms in Romania. Prepared in association with Mușat & Asociații, a leading global law firm, this is an extract from The Pharma Legal Handbook: Romania, available to purchase here for USD 99. 1. Are there proposals for reform or significant change to the healthcare system? The Romanian authorities announced their intention to implement certain changes in the pharmaceutical legislation, including in relation to: the methodology for computing the prices of medicinal products; the clawback tax, a…
A brief overview of the situation regarding patents and trademarks in Romanian Pharma. Prepared in association with Mușat & Asociații, a leading global law firm, this is an extract from The Pharma Legal Handbook: Romania, available to purchase here for USD 99. 1. What are the basic requirements to obtain patent and trademark protection? As a rule, a patent or a trademark protection can only be obtained by registration with the State Office for Inventions and Trademark (“OSIM”), based on the…